# Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers

> **NCT03574428** · PHASE1 · COMPLETED · sponsor: **GeNeuro Australia PTY Ltd** · enrollment: 24 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** GNbAC1
- **OTHER:** GNbAC1 Placebo

## Key facts

- **NCT ID:** NCT03574428
- **Lead sponsor:** GeNeuro Australia PTY Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-08
- **Primary completion:** 2018-11-02
- **Final completion:** 2018-11-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03574428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03574428, "Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03574428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*